Effect of the oral administration of monosodium glutamate during pregnancy and breast-feeding in the offspring of pregnant Wistar rats

Acta Cirurgica Brasileira

Volumn 25, Issue 1, 2010, Pages 37-42

  Von Diemen, Vinicius ^a   Trindade, Manoel Roberto Maciel ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Clinical Hospital   (Brazil)

Author keywords

Obesity; Pregnancy; Rats; Sodium glutamate

Indexed keywords

GLUTAMATE SODIUM; FOOD ADDITIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRTH WEIGHT; BREAST FEEDING; CONTROLLED STUDY; FEMALE; NONHUMAN; PREGNANCY; PROGENY; RAT; VITAMIN SUPPLEMENTATION; WEIGHT GAIN; ANIMAL; BIOMETRY; BODY WEIGHT; DRUG EFFECTS; GROWTH; METABOLISM; NEWBORN; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PRENATAL EXPOSURE; RANDOMIZATION; SUCKLING ANIMAL; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANIMALS, SUCKLING; BIOMETRY; BODY WEIGHT; FEMALE; FOOD ADDITIVES; GROWTH; MODELS, ANIMAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SODIUM GLUTAMATE;

EID: 76149092851     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502010000100010     Document Type: Article

References (35)

1. Nagle AP, Prystowsky JB. Surgical management of obesity. Clin Obstet Gynecol. 2004;47(4):928-41.
2. Livingston EH. Obesity and its surgical management. Am J Surg. 2002;184(2):103-13.
3. Baskin ML, Ard J, Franklin F, Allison DB. Prevalence of obesity in the United States. Obes Rev. 2005;6(1):5-7.
4. Thorburn AW. Prevalence of obesity in Australia. Obes Rev. 2005;6(3):187-9.
5. Rennie KL, Jebb SA. Prevalence of obesity in Great Britain. Obes Rev. 2005;6(1):11-2.
6. Asia Pacific Cohort Studies Collaboration. The burden of overweight and obesity in the Asia-Pacific region. Obes Rev. 2007;8(3):191-6.
7. Hermanussen M, Garcia AP, Sunder M, Voigt M, Salazar V, Tresguerres JA. Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite. Eur J Clin Nutr. 2006;60(1):25-31.
8. Taylor-Burds CC, Westburg AM, Wifall TC, Delay ER. Behavioral comparisons of the tastes of L-alanine and monosodium glutamate in rats. Chem Senses. 2004;29(9):807-14.
9. Diniz YS, Faine LA, Galhardi CM, Rodrigues HG, Ebaid GX, Burneiko RC, Cicogna AC, Novelli EL. Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats. Nutrition. 2005;21(6):749-55.
10. Fernandez-Tresguerres Hernandez JA. [Effect of monosodium glutamate given orally on appetite control (a new theory for the obesity epidemic)]. An R Acad Nac Med (Madr). 2005;122(2):341-55.
11. Fernstrom JD. Pituitary hormone secretion in normal male humans: acute responses to a large, oral dose of monosodium glutamate. J Nutr. 2000;130(4S Suppl):1053S-7S.
12. Dolnikoff M, Martin-Hidalgo A, Machado UF, Lima FB, Herrera E. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord. 2001;25(3):426-33.
13. de Mello MA, de Souza CT, Braga LR, dos Santos JW, Ribeiro IA, Gobatto CA. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. Physiol Chem Phys Med NMR. 2001;33(1):63-71.
14. de Souza CT, Nunes WM, Gobatto CA, de Mello MA. Insulin secretion in monosodium glutamate (MSG) obese rats submitted to aerobic exercise training. Physiol Chem Phys Med NMR. 2003;35(1):43-53.
15. Kanarek RB, Meyers J, Meade RG, Mayer J. Juvenile-onset obesity and deficits in caloric regulation in MSG-treated rats. Pharmacol Biochem Behav. 1979;10(5):717-21.
16. Shivshankar P, Devi SC. Screening of stimulatory effects of dietary risk factors on mouse intestinal cell kinetics. World J Gastroenterol. 2005;11(2):242-8.
17. Bunyan J, Murrell EA, Shah PP. The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr. 1976;35(1):25-39.
18. Filozof C, Gonzalez C, Sereday M, Mazza C, Braguinsky J. Obesity prevalence and trends in Latin-American countries. Obes Rev. 2001;2(2):99-106.
19. Carmo Id, dos Santos O, Camolas J, Vieira J, Carreira M, Medina L, Reis L, Galvao-Teles A. Prevalence of obesity in Portugal. Obes Rev. 2006;7(3):233-7.
20. Rashidi A, Mohammadpour-Ahranjani B, Vafa MR, Karandish M. Prevalence of obesity in Iran. Obes Rev. 2005;6(3):191-2.
21. Beyreuther K, Biesalski HK, Fernstrom JD, Grimm P, Hammes WP, Heinemann U, Kempski O, Stehle P, Steinhart H, Walker R. Consensus meeting: monosodium glutamate - an update. Eur J Clin Nutr. 2007;61(3):304-13.
22. Stegink LD, Pitkin RM, Reynolds WA, Filer LJ, Jr., Boaz DP, Brummel MC. Placental transfer of glutamate and its metabolites in the primate. Am J Obstet Gynecol. 1975;122(1):70-8.
23. Frieder B, Grimm VE. Prenatal monosodium glutamate (MSG) treatment given through the mother's diet causes behavioral deficits in rat offspring. Int J Neurosci. 1984;23(2):117-26.
24. Meguid MM, Ramos EJ, Suzuki S, Xu Y, George ZM, Das UN, Hughes K, Quinn R, Chen C, Marx W, Cunningham PR. A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg. 2004;8(5):621-30.
25. Nakagawa T, Ukai K, Ohyama T, Gomita Y, Okamura H. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines. Exp Anim. 2000;49(4):239-49.
26. Li H, Matheny M, Nicolson M, Tumer N, Scarpace PJ. Leptin gene expression increases with age independent of increasing adiposity in rats. Diabetes. 1997;46(12):2035-9.
27. Souza F, Marchesini JB, Campos AC, Malafaia O, Monteiro OG, Ribeiro FB, Alves HFP, Siroti FJ, Meister H, Mathias PCF. Efeito da vagotomia troncular em ratos injetados na fase neonatal com glutamato monossódico: estudo biométrico. Acta Cir Bras. 2001;16:32-45.
28. Yu T, Zhao Y, Shi W, Ma R, Yu L. Effects of maternal oral administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Brain Res. 1997;747(2):195-206.
29. Kim YW, Choi DW, Park YH, Huh JY, Won KC, Choi KH, Park SY, Kim JY, Lee SK. Leptin-like effects of MTII are augmented in MSG-obese rats. Regul Pept. 2005;127(1-3):63-70.
30. Perello M, Gaillard RC, Chisari A, Spinedi E. Adrenal enucleation in MSG-damaged hyperleptinemic male rats transiently restores adrenal sensitivity to leptin. Neuroendocrinology. 2003;78(3):176-84.
31. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164(880):719-21.
32. Rodriguez-Sierra JF, Sridaran R, Blake CA. Monosodium glutamate disruption of behavioral and endocrine function in the female rat. Neuroendocrinology. 1980;31(3):228-35.
33. Bakke JL, Lawrence N, Bennett J, Robinson S, Bowers CY. Late endocrine effects of administering monosodium glutamate to neonatal rats. Neuroendocrinology. 1978;26(4):220-8.
34. Pizzi WJ, Barnhart JE, Fanslow DJ. Monosodium glutamate admlinistration to the newborn reduces reproductive ability in female and male mice. Science. 1977;196(4288):452-4.
35. Lengvari I. Effect of perinatal monosodium glutamate treatment on endocrine functions of rats in maturity. Acta Biol Acad Sci Hung. 1977;28(1):133-41.